Journal of Thyroid Cancer

Journal of Thyroid Cancer

Journal of Thyroid Cancer – Data Archiving Permissions

Open Access & Peer-Reviewed

Submit Manuscript
Data Archiving Permissions

Support transparent, responsible data sharing for thyroid cancer research.

FAIR DataFindable, accessible, interoperable data.
Patient PrivacyProtect sensitive clinical records.
Code TransparencyShare pipelines and scripts.
Long Term PreservationStable repositories and metadata.

Journal at a Glance

ISSN: 2574-4496
DOI Prefix: 10.14302/issn.2574-4496
License: CC BY 4.0
Peer reviewed open access journal

Scope Alignment

Thyroid carcinoma, endocrine oncology, surgical and medical management, molecular diagnostics, and survivorship care. We prioritize evidence that improves diagnosis and outcomes.

Publishing Model

Open access, single blind peer review, and rapid publication after acceptance and production checks. Metadata validation and DOI registration are included.

Data Archiving Permissions

JTC supports open, responsible data sharing for thyroid cancer research. Authors should deposit data and code in trusted repositories when possible, with clear access instructions.

We recognize that clinical datasets require controlled access due to patient privacy, consent, or regulatory constraints. Authors should document restrictions and access pathways.

Recommended Repositories
  • Clinical data repositories with controlled access and data use agreements
  • Genomics repositories such as GEO, SRA, or EGA
  • Proteomics repositories such as ProteomeXchange
  • Imaging repositories for radiology or pathology data
  • Code repositories such as GitHub or GitLab with release tags
Sensitive Data and Privacy

Patient identifiers must be removed and data should be deidentified in line with applicable privacy regulations. When full sharing is not possible, provide deidentified summaries and clear instructions for requesting access.

Authors should document data governance, including custodians, access review procedures, and consent limits.

Data and Code Availability Statements
  • Include repository links or accession numbers in the manuscript
  • State licensing terms for data and code when applicable
  • Provide documentation for custom scripts or pipelines
  • Describe any access restrictions and approval requirements
Preferred File Formats
Data Type Preferred Formats Notes
Clinical datasets CSV, TSV Include data dictionaries
Imaging data DICOM, NIfTI Provide acquisition protocols
Genomics/omics FASTQ, BAM, VCF Include pipeline details
Pathology images TIFF, SVS Include staining protocols
 
Data Archiving FAQ

Can I embargo data?

Yes. Provide embargo details and expected release dates.

What if data are proprietary?

Explain restrictions and provide access request steps.

Is code sharing required?

We strongly encourage code sharing or detailed documentation.

JTC Commitment

JTC is committed to rigorous, transparent publishing in thyroid cancer research and care. We emphasize reproducible clinical methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in endocrine oncology, surgical outcomes, and translational thyroid research.

Need Data Sharing Guidance?

Contact the editorial office for questions about repositories or permissions.

Public Access and Funder Compliance

Some authors are required by their funders to make their research publicly available. Under the 2024 NIH Public Access Policy, Author Accepted Manuscripts accepted for publication on or after July 1, 2025, must be submitted to PubMed Central upon acceptance and made publicly available without embargo on the official date of publication.

What JTC provides: JTC publishes the Version of Record under the Creative Commons Attribution 4.0 International licence. The journal also permits authors to deposit their Author Accepted Manuscript in funder-designated repositories. Upon acceptance, we confirm the accepted manuscript version and record the funder and grant information supplied by the authors.

Author responsibility: JTC does not currently deposit manuscripts in PubMed Central on behalf of authors. Authors are responsible for determining which funder requirements apply, initiating the appropriate repository submission and completing any required NIHMS approval steps.

Eligibility and successful processing through PubMed Central or NIHMS are determined according to the relevant funder and NIH/NLM requirements.

Important: The deposit of an individual article in PubMed Central may result in that article appearing in PubMed. It does not mean that JTC is indexed in MEDLINE, included in the PMC Journal List or that all JTC articles are available through PubMed. The journal's current coverage is listed on the Indexing page.